Eterna Therapeutics Inc. (NASDAQ: ERNA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ETERNA THERAPEUTICS INC.

Eterna Therapeutics Inc. (NASDAQ: ERNA)
Listen to this Section


$7.86
-0.3290 ( -4.02% ) 25.2K

Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.

Market Data


Open $7.86
Previous Close $8.19
Volume 25.2K
Market Cap $9.34M
Day Range $7.65 - $8.36
52 Week Range $3.18 - $75.00
Shares Outstanding 1.17M
Change % -4.02%
Net Change ▼ -0.3290
Insider Ownership 0.03%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2021
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 25,213,868.00

Date Type Amount Purchased Purchaser
2025-06-11 Buy 21241163.00 Cherington Charles
2024-11-05 Buy 261756.00 Cherington Charles
2024-06-25 Sale -437.00 Gurrola Sandra M
2024-04-29 Sale -88946.00 Cicala Peter
2024-04-29 Sale -80000.00 Gurrola Sandra M
2024-04-29 Sale -124525.00 Bristol James Arthur
2024-01-03 Sale -1685218.00 Luther Sanjeev
2024-01-03 Sale -168521.00 Clarke Dorothy J
2023-12-20 Buy 3125976.00 Cherington Charles
2023-12-18 Buy 424928.00 Freebird Partners LP

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 77 Nov 07, 2025
10-q Quarterly Reports 75 Aug 13, 2025
8-k 8K-related 13 Jul 07, 2025
4 Insider transactions 1 Jul 07, 2025
8-k 8K-related 13 Jun 12, 2025
4 Insider transactions 1 Jun 11, 2025
8-k 8K-related 12 Jun 09, 2025
8-k 8K-related 14 Jun 02, 2025

Latest News


× Before browsing our site, please accept our cookies policy